HealthNotableReportedDeveloping
5.2
Brazil's Anvisa Approves First Human Trial of Nationally Developed Malaria Vaccine
Poder360·BR·about 7 hours ago
Brazil's health regulator Anvisa ordered a full recall of all batches of the dietary supplement Peptistrong because its formulation never underwent a safety evaluation. The recall signals a regulatory compliance failure rather than confirmed harm, and its market impact is limited to the product's manufacturer and distributors.